Russia restricts government procurement of foreign medicine

On 10 December 2015, Russian Government Resolution No. 1289 of 30 November 2015 (hereinafter, “Resolution No. 1289”), which restricts the inclusion of foreign medical products on the list of Vital and Essential Medicines, was enacted. The resolution was published on the official website of the Government of the Russian Federation on 2 December 2015.

The resolution was prepared by the Ministry of Industry and Trade in 2015 as part of the implementation of the Plan of Priority Measures to Ensure Sustainable Economic Development and Social Stability. However, discussions on restricting imported medicines in government procurement have been ongoing since 2013.

Key contacts

Partner, Tax&Legal

Oleg joined Deloitte in 2003. He has 20 years of tax consulting experience and currently heads the Indirect Tax & Customs group, the Life Sciences and Healthcare Industry group and the Chinese Service... More

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see www.deloitte.com/about to learn more about our global network of member firms.